Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhiqin Zhang, Lihua Ni, Lian Zhang, Dongqing Zha, Chun Hu, Lingli Zhang, Huiling Feng, Xiaobao Wei, Xiaoyan Wu Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaCorrespondence: Xiaoyan WuDepartment of Nephrology, Zhongnan Hospital of W...

Full description

Bibliographic Details
Main Authors: Zhang Z, Ni L, Zhang L, Zha D, Hu C, Feng H, Wei X, Wu X
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
diabetic nephropathy
empagliflozin
adipor1
p-ampk
p-acc
lipid
Online Access:https://www.dovepress.com/empagliflozin-regulates-the-adipor1p-ampkp-acc-pathway-to-alleviate-li-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/empagliflozin-regulates-the-adipor1p-ampkp-acc-pathway-to-alleviate-li-peer-reviewed-article-DMSO

Similar Items